CAS 648895-38-9

Bapineuzumab

CAS: 648895-38-9

Anti-β-amyloid protein (APP) monoclonal antibody.

Ref: 3D-CLA1652

Bapineuzumab

CAS: 648895-38-9

Bapineuzumab (AAB-001) is a humanised monoclonal antibody targeting amyloid-beta (Aβ), soluble and oligomeric forms of amyloid β, Alzheimer's disease (AD).

Reinheit: 95%

Farbe und Form: Liquid

Molekulargewicht: 145.86 kDa

Ref: TM-T76738